Memantine in Patients With Chronic Glaucoma

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized double-masked clinical trial of memantine in patients with glaucoma

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Memantine

Criteria

Inclusion Criteria:

• glaucoma damage on examination of visual field and optic disc

• good visual acuity (with glasses if needed)